A Comprehensive Introduction to Magnetic Resonance Imaging Relaxometry and Contrast Agents.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
25 Oct 2022
Historique:
received: 07 06 2022
accepted: 30 09 2022
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 1 11 2022
Statut: epublish

Résumé

The development of imaging technologies allowing noninvasive observation through solid bodies has represented a breakthrough in medical diagnosis, facilitating the comprehension of biomolecular events underlying disease and the development of more efficient therapeutic approaches. Some of the traditional limitations of these techniques are nowadays fading away thanks to the combination of imaging with nanotechnology, allowing the development of novel functional biomaterials that increase the sensitivity of detection, enable sensitivity to specific targets, and facilitate the combination of therapeutic and diagnostic functions (theragnosis) with molecular platforms functioning simultaneously as imaging probes and drug delivery carriers. The design of such functional biomaterials requires a comprehensive understanding of the principles that govern the generation of signal and modulation of contrast for a given imaging modality to exploit its capabilities to the maximal level. In this sense, magnetic resonance imaging (MRI) is a technique that presents a complex relationship between the detected signal and the physical-chemical properties of its sourcing matter, allowing the generation of multiple image contrasts. Thus, while magnetic resonance imaging is a highly versatile imaging modality, it requires specific knowledge of its physical principles to take advantage of all of its possibilities. This work reviews the origin of the image signal and contrast in MRI and the concepts of relaxometry and MRI contrast agents.

Identifiants

pubmed: 36312407
doi: 10.1021/acsomega.2c03549
pmc: PMC9609087
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

36905-36917

Informations de copyright

© 2022 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Mol Imaging. 2005 Apr-Jun;4(2):104-9
pubmed: 16105508
Chem Soc Rev. 2006 Jun;35(6):512-23
pubmed: 16729145
ACS Nano. 2014 Apr 22;8(4):3393-401
pubmed: 24673493
Handb Exp Pharmacol. 2008;(185 Pt 1):135-65
pubmed: 18626802
Bioconjug Chem. 2015 Mar 18;26(3):443-51
pubmed: 25650634
Chem Commun (Camb). 2013 Oct 28;49(84):9704-21
pubmed: 24040650
Theranostics. 2013 Dec 12;4(1):90-105
pubmed: 24396517
Phys Med Biol. 2017 Jul 7;62(13):R81-R123
pubmed: 28384123
MAGMA. 2012 Jun;25(3):245-9
pubmed: 22071580
J Magn Reson Imaging. 2012 Oct;36(4):805-24
pubmed: 22987758
Nanomedicine (Lond). 2011 Apr;6(3):519-28
pubmed: 21542689
NMR Biomed. 2013 Jul;26(7):839-49
pubmed: 23784956
Chem Rev. 2019 Jan 23;119(2):957-1057
pubmed: 30350585
Chem Soc Rev. 2012 Apr 7;41(7):2656-72
pubmed: 22189429

Auteurs

Saioa Alzola-Aldamizetxebarria (S)

Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Spain.
Achucarro Basque Center for Neuroscience, 48940 Leioa, Spain.

Laura Fernández-Méndez (L)

Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Spain.

Daniel Padro (D)

Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Spain.

Jesús Ruíz-Cabello (J)

Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Spain.
Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.
CIBER de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain.
Departamento de Química en Ciencias Farmacéuticas, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Pedro Ramos-Cabrer (P)

Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Spain.
Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.

Classifications MeSH